1377-84.
[15] Fedele D, Comi G, Coscelli C, Cucinotta D, Feldman EL, Ghirlanda G, Greene DA, Negrin P, Santeusanto F. A multicenter study on the prevalence of diabetic neuropathy in Italy. Italian Diabetic Neuropathy Committee. Diabetes Care 1997; 20: 836-43.
[16] Wikblad K, Smide B, Bergstrom A, Kessi J, Mugusi F. Outcome of clinical foot examination in relation to self-perceived health and glycaemic control in a group of urban Tanzanian diabetic patients. Diabetes Res Clin Pract 1997; 37: 185-92.
[17] Adler AI, Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Smith DG. Risk factors for diabetic peripheral sensory neuropathy. Results of the Seattle Prospective Diabetic Foot Study. Diabetes Care 1997; 20: 1162-7.
[18] Beghi E, Monticelli ML. Diabetic polyneuropathy in the elderly. Prevalence and risk factors in two geographic areas of Italy. Italian General Practitioner Study Group (IGPSG). Acta Neurol Scand 1997; 96: 223-8.
[19] Cabezas-Cerrato J. The prevalence of clinical diabetic polyneuropathy in Spain: a study in primary care and hospital clinic groups. Neuropathy Spanish Study Group of the Spanish Diabetes Society (SDS). Diabetologia 1998; 41: 1263-9.
[20] Franklin GM, Shetterly SM, Cohen JA, Baxter J, Hamman RF. Risk factors for distal symmetric neuropathy in NIDDM. San Luis Val Diabetes Study. Diabetes Care 1994; 17: 1172-7.
[21] Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, Wilson DM, O'Brien PC, Melton LJ 3d, Service FJ. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993; 43: 817-24.
[22] Kumar S, Ashe HA, Parnell LN, Fernando DJ, Tsigos C, Young RJ, Ward JD, Boulton AJM. The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population-based study. Diabet Med 1994; 11: 480-4.
[23] Knuiman MW, Welborn TA, McCann VJ, Stanton KG, Constable IJ. Prevalence of diabetic complications in relation to risk factors. Diabetes 1986; 35: 1332-9.
[24] Fujimoto WY, Leonetti DL, Kinyoun JL, Shuman WP, Stolov WC, Wahl PW. Prevalence of complications among second-generation Japanese-American men with diabetes, impaired glucose tolerance, or normal glucose tolerance. Diabetes 1987; 36: 730-9.
[25] Maser RE. Steenkiste AR, Dorman JS, Kamp Nielsen V, Bass EB, Manjoo Q, Drash AL, Becker DJ, Kuller LH, Greene DA, Orchard TJ. Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 1989; 38: 1456-61.
[26] Harris M, Eastman R, Cowie C. Symptoms of sensory neuropathy in adults with NIDDM in the US population. Diabetes Care 1993; 16: 1446-52.
[27] Nielsen JV. Peripheral neuropathy, hypertension, foot ulcers and amputations among Saudi Arabian patients with type 2 diabetes. Diabetes Res Clin Pract 1998; 41: 63-9.
[28] Verhoeven S, Ballegooie E van, Casparie AF. Impact of late complications in type 2 diabetes in a Dutch population. Diabet Med 1991; 8: 435-8.
[29] Neeling JND De, Beks PJ, Bertelsmann FW, Heine RJ, Bouter LM. Peripheral somatic nerve function in relation to glucose tolerance in an elderly Caucasian population: the Hoorn Study. Diabet Med 1996; 13: 960-6.
[30] Müller UA, Ross IS, Klinger H. Häufigkeit der Hypopallästhesie bei insulinspritzenden Diabetikern in einer unausgewählten Stadtpopulation, Diab Stoffw 1993; 2: 439-42.
[31] Ziegler D, Gries FA, Mühlen H, Rathmann W, Spüler M, Lessmann F, the DiaCAN Multicenter Study Group. Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes centers. Diab Metab 1993; 19: 143-51.
[32] Veglio M, Sivieri R. Prevalence of neuropathy in IDDM patients in Piemonte, Italy. The Neuropathy Study Croup of the Italian Society for the Study of Diabetes. Piemonte Affiliate. Diabetes Care 1993; 16: 456-61.
[33] Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995; 333: 89-94.
[34] Ratzmann KP, Raschke M, Gander B, Schimke P. Prevalence of peripheral and autonomic neuropathy in newly diagnosed type II (noninsulin dependent) diabetes. J Diab Complications 1991; 5: 1-5.
[35] Wang WQ, Ip TP, Lam KS. Changing prevalence of retinopathy in newly diagnosed non-insulin dependent diabetes mellitus patients in Hong Kong. Diabetes Res Clin Pract 1998; 39: 185-91.
[36] Gujral JS, McNally PG, O'Malley BP, Burden AC. Ethnic differences in the incidence of lower extremity amputation secondary to diabetes mellitus. Diabet Med 1993; 10: 271-4.
[37] Bharucha NE, Bharucha AE, Bharucha EP. Prevalence of peripheral neuropathy in the Parsi community of Bombay. Neurology 1991; 41: 1315-7.
[38] Savettieri G, Rocca WA, Salemi G, Meneghini F, Grigoletto F, Morgante L, Reggio A, Costa V, Coraci MA, Di Perri R. Prevalence of diabetic neuropathy with somatic symptoms: a door-to-door survey in two Sicilian municipalities. Neurology 1993; 43: 1115-20.
[39] Watkins PJ. The natural history of the diabetic neuropathies. Q J Med 1990; 77: 1209-18.
[40] Eriksson KF, Nilsson H, Lindgärde F, Österlin S, Dahlin LB, Lilja B, Rosen I, Sundkvist G. Diabetes mellitus but not impaired glucose tolerance is associated with dysfunction of peripheral nerves. Diabet Med 1994; 11: 279-85.
[41] Sosenko JM, Kato M, Soto R, Goldberg RB. Sensory function at diagnosis and in early stages of NIDDM in patients detected through screening. Diabetes Care 1992; 15: 847-52.
[42] Sundkvist G, Dahlin L-B, Nilsson H, Eriksson K-F, Lindgärde F, Rosen I, Lattimer SA, Sima AAF, Sullivan K, Greene DA. Sorbitol and myo-inositol levels and morphology of sural nerve in relation to peripheral nerve function and clinical neuropathy in men with diabetic, impaired, and normal glucose tolerance. Diabet Med 2000; 17: 259-68.
[43] Melton III LJ, Dyck PJ. Epidemiology. In: Dyck PJ, rhomas PK, Asbury AK, Winegrad AI, Porte D Jr, editors. Diabetic neuropathy. Philadelphia, Pa: W. B. Saunders; 1987: 27-35.
[44] Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 197DiabetesCare 1978; 252: 168-88.
[45] Töyry JP, Partanen JVS, Niskanen LK, Länsimies EA, Uusitupa MIJ. Divergent development of autonomic and peripheral somatic neuropathies in NIDDM. Diabetologia 1997; 40: 953-8.
[46] UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53.
[47] Sands ML, Shetterly SM, Franklin GM, Hamman RF. Incidence of distal symmetric (sensory) neuropathy in NIDDM. San Luis Val Diabetes Study. Diabetes Care 1997; 20: 322-9.
[48] Dyck PJ, Davies JL, Litchy WJ, O'Brien PC. Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology 1997; 49: 229-39.
[49] Forrest KY, Maser RE, Pambianco G, Becker DJ, Orchard TJ. Hypertension as a risk factor for diabetic neuropathy: a prospective study. Diabetes 1997; 46: 665-70.
[50] Tesfaye S, Chaturvedi N, Eaton SEM, Ward JD, Fuller JH. Cardiovascular risk factors predict the development of diabetic peripheral neuropathy. Diabetes 2000; 49 (Suppl 1): A34.
[51] Hillson RM, Hockaday TDR, Newton DJ. Hyperglycaemia is one correlate of deterioration in vibration sense during the 5 years after diagnosis of type 2 (non-insulin-dependent) diabetes. Diabetologia 1984; 26: 122-6.
[52]
